Inventor · disambiguated record
Hans-Jürgen Wester
Also filed as: WESTER HANS JURGEN · WESTER HANS-JUERGEN · WESTER HANS-JURGEN PETER · WESTER HANS-JÜRGEN
17 granted patents·16 pending applications·62 citations·filing 2002–2025
91Inventor score
Files withUNIV MUENCHEN TECH23WESTER HANS JUERGEN2ACADEMISCH ZIEKENHUIS LEIDEN1BERNDT MATHIAS1DEMMER OLIVER1
Top patents by PatentIndex Score
33 records- 0188US11497819B2PSMA ligands for imaging and endoradiotherapyUNIV MUENCHEN TECH·Filed 2018·Granted Nov 15, 2022·5 cites·37 claims
- 0287US8614290B2Cancer imaging and treatmentWESTER HANS JUERGEN·Filed 2008·Granted Dec 24, 2013·17 cites·2 claims
- 0386US8628750B2Cancer imaging and treatmentWESTER HANS JUERGEN·Filed 2007·Granted Jan 14, 2014·18 cites·19 claims
- 0484US12453787B2Dual mode radiotracer and-therapeuticsUNIV MUENCHEN TECH·Filed 2024·Granted Oct 28, 2025·0 cites·7 claims
- 0584US11413360B2Dual mode radiotracer and—therapeuticsUNIV MUENCHEN TECH·Filed 2018·Granted Aug 16, 2022·2 cites·16 claims
- 0678US11944691B2CXCR4-targeted diagnostic and therapeutic agents with reduced species selectivityUNIV MUENCHEN TECH·Filed 2019·Granted Apr 2, 2024·1 cites·10 claims
- 0777US8575100B2Tc and Re labeled radioactive glycosylated octreotide derivativesWESTER HANS-JURGEN·Filed 2009·Granted Nov 5, 2013·3 cites·8 claims
- 0876US11639373B2Therapeutic and diagnostic agents for cancerUNIV MUENCHEN TECH·Filed 2019·Granted May 2, 2023·1 cites·28 claims
- 0975US12390540B2Dual mode radiotracer and -therapeuticsUNIV MUENCHEN TECH·Filed 2022·Granted Aug 19, 2025·0 cites·16 claims
- 1074US9266924B2Cyclopentapeptide derivatives and uses thereofDEMMER OLIVER·Filed 2011·Granted Feb 23, 2016·5 cites·17 claims
- 1174US9260483B2Triazacyclononane-based phosphinate ligand and its use for molecular imagingNOTNI JOHANNES·Filed 2012·Granted Feb 16, 2016·6 cites·6 claims
- 1270US10919938B2Modified cyclopentapeptides and uses thereofUNIV MUENCHEN TECH·Filed 2014·Granted Feb 16, 2021·2 cites·11 claims
- 1367US2024293587A1Cxcr4-targeted diagnostic and therapeutic agents with reduced species selectivityUNIV MUENCHEN TECH·Filed 2024·Application pending·0 cites
- 1466US2025375544A1Dual mode radiotracer and -therapeuticsUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 1565US2025295819A1PSMA binding dual mode radiotracer and therapeuticsUNIV MUENCHEN TECH·Filed 2025·Application pending·0 cites
- 1663US2023122957A1Psma ligands for imaging and endoradiotherapyUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 1763US2024066155A1Dual mode radiotracer and -therapeuticsUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 1860US12357711B2PSMA binding dual mode radiotracer and therapeuticUNIV MUENCHEN TECH·Filed 2020·Granted Jul 15, 2025·0 cites·14 claims
- 1959US7589061B2Tc and Re labeler radioactive glycosylated octreotide derivativesMALLINCKRODT INC·Filed 2002·Granted Sep 15, 2009·2 cites·25 claims
- 2058US2014039153A1Cancer imaging and treatmentUNIV MUENCHEN TECH·Filed 2013·Application pending·0 cites
- 2153US2024165281A1Dual mode radiotracer and therapeuticsUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 2253US2025313579A1Ligand compounds comprising a chelating group as a bridging groupUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 2352US2025339567A1Compounds with improved pharmacokinetics for imaging and therapy of cancerUNIV MUENCHEN TECH·Filed 2020·Application pending·0 cites
- 2452US2024317780A1Radiopharmaceutical somatostatin receptor ligands and precursors thereofUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 2551US12377176B2Cancer diagnostic imaging agentsUNIV MUENCHEN TECH·Filed 2020·Granted Aug 5, 2025·0 cites·6 claims
- 2650US2023277698A1Silicon-containing ligand compoundsUNIV MUENCHEN TECH·Filed 2021·Application pending·0 cites
- 2749US2010081799A1Chelating AgentKNOER SEBASTIAN·Filed 2007·Application pending·0 cites
- 2848US2025288704A1Cxcr4-ligands for diagnostic and therapeutic use and precursors thereofUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 2947US2014100172A1Cancer Imaging and TreatmentMALLINCKRODT LLC·Filed 2013·Application pending·0 cites
- 3041US2025051245A1Method for the preparation of a composition comprising dissolved [18f]fluoride and composition obtainable by the methodUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 3134US12419976B2Hybrid tracers for targeted cancer imaging and treatmentACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Granted Sep 23, 2025·0 cites·17 claims
- 3228US10328163B2Compounds binding to neuropathological aggregatesUNIV MUENCHEN TECH·Filed 2015·Granted Jun 25, 2019·0 cites·19 claims
- 3326US2013149243A1Method for production of f-18 labeled glutamic acid derivativesBERNDT MATHIAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hans-Jürgen Wester files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →